Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Apr 21, 2025 |
print number 1248a |
Apr 21, 2025 |
amend (t) and recommit to ways and means |
Apr 02, 2025 |
reported referred to ways and means |
Mar 25, 2025 |
reported referred to codes |
Jan 09, 2025 |
referred to consumer affairs and protection |
Assembly Bill A1248A
2025-2026 Legislative Session
Sponsored By
TAPIA
Current Bill Status - In Assembly Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Bill Amendments
co-Sponsors
John Zaccaro Jr.
George Alvarez
Charles Lavine
Manny De Los Santos
2025-A1248 - Details
2025-A1248 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 1248 2025-2026 Regular Sessions I N A S S E M B L Y January 9, 2025 ___________ Introduced by M. of A. TAPIA, ZACCARO, ALVAREZ, LAVINE, DE LOS SANTOS, SIMONE, FORREST, SHIMSKY, LUCAS, CUNNINGHAM, CRUZ, SIMON, SAYEGH, EPSTEIN, BICHOTTE HERMELYN, BORES, K. BROWN, CHANG, GIGLIO, PIROZZOLO, DeSTEFANO -- read once and referred to the Committee on Consumer Affairs and Protection AN ACT to amend the general business law, in relation to prohibiting the sale of xylazine THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The general business law is amended by adding a new section 392-k to read as follows: § 392-K. SALE OF XYLAZINE. 1. FOR PURPOSES OF THIS SECTION, THE TERM "XYLAZINE" SHALL MEAN A PHARMACEUTICAL DRUG USED FOR SEDATION, ANES- THESIA, MUSCLE RELAXATION, AND ANALGESIA IN ANIMALS SUCH AS HORSES, CATTLE, AND OTHER NON-HUMAN MAMMALS. 2. NO CORPORATION, PARTNERSHIP, LIMITED LIABILITY COMPANY, FIRM, ONLINE PLATFORM, OR ANY OTHER BUSINESS ENTITY DOING BUSINESS WITHIN THIS STATE SHALL KNOWINGLY SELL, OFFER FOR SALE, OR DELIVER XYLAZINE TO INDI- VIDUALS WITHOUT PROOF OF ITS INTENDED USE FOR INSTITUTIONAL, VETERINARY, OR SCIENTIFIC PURPOSES. 3. NO CORPORATION, PARTNERSHIP, LIMITED LIABILITY COMPANY, FIRM, ONLINE PLATFORM, OR OTHER BUSINESS ENTITY DOING BUSINESS WITHIN THIS STATE SHALL KNOWINGLY SELL, OFFER FOR SALE, OR DELIVER XYLAZINE TO INDI- VIDUALS UNDER THE AGE OF TWENTY-ONE. 4. ANY CORPORATION, PARTNERSHIP, LIMITED LIABILITY COMPANY, FIRM, ONLINE PLATFORM OR OTHER BUSINESS ENTITY DOING BUSINESS WITHIN THIS STATE WHICH KNOWINGLY SELLS, OFFERS FOR SALE, OR DISTRIBUTES XYLAZINE, SHALL REQUIRE AND RETAIN SALES RECORDS, PROOF OF AGE, AND PROOF OF USE FROM ALL PURCHASERS. 5. ANY CORPORATION, PARTNERSHIP, LIMITED LIABILITY COMPANY, FIRM, ONLINE PLATFORM, OR OTHER BUSINESS ENTITY DOING BUSINESS WITHIN THIS EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD02623-01-5
co-Sponsors
John Zaccaro Jr.
George Alvarez
Charles Lavine
Manny De Los Santos
2025-A1248A (ACTIVE) - Details
2025-A1248A (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 1248--A 2025-2026 Regular Sessions I N A S S E M B L Y January 9, 2025 ___________ Introduced by M. of A. TAPIA, ZACCARO, ALVAREZ, LAVINE, DE LOS SANTOS, SIMONE, FORREST, SHIMSKY, LUCAS, CUNNINGHAM, CRUZ, SIMON, SAYEGH, EPSTEIN, BICHOTTE HERMELYN, BORES, K. BROWN, CHANG, GIGLIO, PIROZZOLO, DeSTEFANO, PHEFFER AMATO, WEPRIN -- read once and referred to the Committee on Consumer Affairs and Protection -- reported and referred to the Committee on Codes -- reported and referred to the Committee on Ways and Means -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the general business law, in relation to prohibiting the sale of xylazine above a certain weight THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The general business law is amended by adding a new section 392-k to read as follows: § 392-K. SALE OF XYLAZINE. 1. FOR PURPOSES OF THIS SECTION, THE TERM "XYLAZINE" SHALL MEAN A PHARMACEUTICAL DRUG USED FOR SEDATION, ANES- THESIA, MUSCLE RELAXATION, AND ANALGESIA IN ANIMALS SUCH AS HORSES, CATTLE, AND OTHER NON-HUMAN MAMMALS. 2. THE PROVISIONS OF THIS SECTION SHALL APPLY ONLY TO THE SALE, OFFER FOR SALE, DELIVERY, OR DISTRIBUTION OF XYLAZINE IN QUANTITIES OF FIFTY GRAMS OR MORE. 3. NO CORPORATION, PARTNERSHIP, LIMITED LIABILITY COMPANY, FIRM, ONLINE PLATFORM, OR ANY OTHER BUSINESS ENTITY DOING BUSINESS WITHIN THIS STATE SHALL KNOWINGLY SELL, OFFER FOR SALE, OR DELIVER FIFTY GRAMS OR MORE OF XYLAZINE TO INDIVIDUALS WITHOUT PROOF OF ITS INTENDED USE FOR INSTITUTIONAL, VETERINARY, OR SCIENTIFIC PURPOSES. 4. NO CORPORATION, PARTNERSHIP, LIMITED LIABILITY COMPANY, FIRM, ONLINE PLATFORM, OR OTHER BUSINESS ENTITY DOING BUSINESS WITHIN THIS STATE SHALL KNOWINGLY SELL, OFFER FOR SALE, OR DELIVER FIFTY GRAMS OR MORE OF XYLAZINE TO INDIVIDUALS UNDER THE AGE OF TWENTY-ONE. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD02623-04-5 A. 1248--A 2
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.